BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37759458)

  • 21. Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis.
    Massarenti L; Enevold C; Damgaard D; Hansen PR; Frisch M; Ødum N; Jacobsen S; Nielsen CH
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies,
    Guderud K; Mæhlen MT; Nordang GBN; Viken MK; Andreassen BK; Molberg Ø; Flåm ST; Lie BA
    J Rheumatol; 2018 Aug; 45(9):1211-1219. PubMed ID: 29858238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
    Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
    Front Immunol; 2018; 9():2696. PubMed ID: 30515171
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
    Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
    Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
    Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
    Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
    Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.
    Giles JT; Darrah E; Danoff S; Johnson C; Andrade F; Rosen A; Bathon JM
    PLoS One; 2014; 9(6):e98794. PubMed ID: 24901704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed puberty, gonadotropin abnormalities and subfertility in male Padi2/Padi4 double knockout mice.
    Sams KL; Mukai C; Marks BA; Mittal C; Demeter EA; Nelissen S; Grenier JK; Tate AE; Ahmed F; Coonrod SA
    Reprod Biol Endocrinol; 2022 Oct; 20(1):150. PubMed ID: 36224627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of MiRNA-146a, MiRNA-499, IRAK1 and PADI4 Polymorphisms with Rheumatoid Arthritis in Egyptian Population.
    Shaker OG; El Boghdady NA; El Sayed AE
    Cell Physiol Biochem; 2018; 46(6):2239-2249. PubMed ID: 29734142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of
    Gutiérrez-Pérez IA; Buendía-Roldán I; Zaragoza-García O; Pérez-Rubio G; Villafan-Bernal JR; Chávez-Galán L; Parra-Rojas I; Hernández-Zenteno RJ; Fricke-Galindo I; Castro-Alarcón N; Bautista-Becerril B; Falfán-Valencia R; Guzmán-Guzmán IP
    Heliyon; 2024 Mar; 10(6):e27997. PubMed ID: 38524554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphic Analysis of Genes PADI4 (rs2240340, rs1748033) and HLA-DRB1 (rs2395175) in Arthritis Patients in Pakistani Population.
    Bashir K; Chaudhary A; Aslam M; Fatima I; Sarwar R
    Biochem Genet; 2024 Jun; 62(3):1840-1856. PubMed ID: 37751115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
    Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
    Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of single nucleotide polymorphisms (SNPs) of PADI4 gene with rheumatoid arthritis (RA) in Indian population.
    Panati K; Pal S; Rao KV; Reddy VD
    Genes Genet Syst; 2012; 87(3):191-6. PubMed ID: 22976394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.
    Cheng J; Zhang H; Zhuang C; Liu R
    J Rheumatol; 2012 Jun; 39(6):1159-65. PubMed ID: 22505706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.
    Abd-Allah SH; el-Shal AS; Shalaby SM; Pasha HF; Abou el-Saoud AM; el-Najjar AR; el-Shahawy EE
    Joint Bone Spine; 2012 Mar; 79(2):124-8. PubMed ID: 21981985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PADI4 Polymorphisms in Iranian Patients with Rheumatoid Arthritis.
    Shamsian E; Azarian M; Akhlaghi M; Samaei M; Jamshidi AR; Assar S; Shakiba Y; Gharibdoost F; Nourijelyani K; Mahmoudi M
    Acta Reumatol Port; 2016; 41(4):338-343. PubMed ID: 27182695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.